Compare Davita Inc (DVA) vs Otis Worldwide Corp (OTIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Otis Worldwide Corp — how do they compare? Davita Inc trades at $175.04 (market cap $11.28B), while Otis Worldwide Corp trades at $66.12 (market cap $25.03B). The key difference: Otis Worldwide Corp is far larger — about 2.2× Davita Inc's market cap, and Otis Worldwide Corp pays a 2.68% dividend while Davita Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and Otis Worldwide Corp for 65 Days on average.
| DVA | OTIS | |
|---|---|---|
Market Cap | $11.28B | $25.03B |
Volume | 650,294 | 2,974,901 |
Sector | Health | Industrials |
52-Week High | $240.96 | $93.62 |
52-Week Low | $103.87 | $64.05 |
Typical Hold Time | 113 Days | 65 Days |
Enterprise Value | $24.00B | $33.06B |
Dividend Yield | — | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $177.02, down 1.87% on the day, showing mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company demonstrates strong earnings beats with Q2 2026 EPS of $4.02 exceeding expectations of $3.88, while revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026. Recent developments include expanding value-based care partnerships with Humana, potentially benefiting over 10,000 Medicare Advantage members.
The outlook remains cautiously optimistic with 43% analyst buy ratings and a $235.67 consensus price target suggesting 33% upside. However, rising debt-to-asset ratios (65.55% in 2025) and margin pressures from Q2 2026 create headwinds. Key risks include regulatory changes in healthcare reimbursement and competitive pressures in dialysis services.
Otis Worldwide trades at $66.11, down 0.51% on the day and near its 52-week low. The stock shows bearish technical signals with mixed analyst sentiment (46.7% buy, 46.7% hold). Recent earnings have missed expectations for three consecutive quarters, though the company maintains stable revenue around $14.4 billion and strong service-based cash flows. CEO succession plans for 2027 and margin pressures in China remain key focus areas.
The investment outlook balances Otis's market leadership in elevator services against near-term headwinds. Upside potential exists if service margins recover and China demand stabilizes, supported by a consensus price target of $87.00. However, risks include persistent cost pressures, weak equipment demand, and high debt levels with a debt-to-asset ratio of 75.54% in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →
